DiaMedica Therapeutics (DMAC) News Today → What is the 72-Hour Profit Surge? (From DTI) (Ad) Free DMAC Stock Alerts $2.53 +0.08 (+3.27%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDiaMedica Therapeutics (NASDAQ:DMAC) Earns Buy Rating from Analysts at Craig Hallummarketbeat.com - April 24 at 10:46 AMDiaMedica Therapeutics (NASDAQ:DMAC) Shares Down 3.6% marketbeat.com - April 24 at 12:43 AMDiaMedica Therapeutics Announces First Patient Dosed in Relaunch of its Pivotal Phase 2/3 ReMEDy2 Trial of DM199 for the Treatment of Acute Ischemic Strokebusinesswire.com - April 17 at 4:08 PMDiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 25 at 1:07 PMWall Street's Favorite Penny Stocks? 7 Names That Could Make You Filthy Richinvestorplace.com - March 23 at 6:00 AMDiaMedica Therapeutics Inc. (DMAC) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 22 at 6:49 PMCraig Hallum Cuts DiaMedica Therapeutics (NASDAQ:DMAC) Price Target to $8.00marketbeat.com - March 21 at 2:52 PMDiaMedica Therapeutics' (DMAC) Outperform Rating Reiterated at Oppenheimermarketbeat.com - March 21 at 9:38 AMDiaMedica Therapeutics (NASDAQ:DMAC) Announces Quarterly Earnings Resultsmarketbeat.com - March 20 at 8:47 AMDMAC Stock Earnings: DiaMedica Therapeutics Meets EPS for Q4 2023investorplace.com - March 19 at 9:53 PMRecap: DiaMedica Therapeutics Q4 Earningsbenzinga.com - March 19 at 7:30 PMDiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Resultsbusinesswire.com - March 19 at 4:15 PMTryp Therapeutics Inc. (TRYP.CN)ca.finance.yahoo.com - March 6 at 4:00 PMDiaMedica Therapeutics Stock (NASDAQ:DMAC) Dividends: History, Yield and Datesbenzinga.com - February 9 at 8:39 PMDiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Significant Growth in Short Interestmarketbeat.com - February 1 at 10:18 AMDiaMedica Therapeutics Announces Poster Presentation at International Stroke Conferencefinance.yahoo.com - January 29 at 6:04 PMDiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) largest shareholders are individual investors with 52% ownership, insiders own 37%finance.yahoo.com - January 7 at 10:04 AMShort Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Increases By 5.3%marketbeat.com - January 3 at 6:25 PMShort Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Declines By 24.9%marketbeat.com - December 16 at 12:23 AMHere's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situationfinance.yahoo.com - December 11 at 8:35 AMDiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 15 at 3:10 PMAnalysts’ Top Healthcare Picks: Diamedica Therapeutics (DMAC), Abivax SA Sponsored ADR (ABVX)markets.businessinsider.com - November 14 at 11:48 PMQ3 2023 DiaMedica Therapeutics Inc Earnings Callfinance.yahoo.com - November 14 at 11:48 PMDiaMedica Therapeutics Inc. (DMAC) Reports Third Quarter 2023 Financial Resultsgurufocus.com - November 14 at 3:22 PMDiaMedica Therapeutics Insiders Placed Bullish Bets Worth US$20.2mfinance.yahoo.com - November 14 at 8:38 AMDiaMedica Therapeutics GAAP EPS of -$0.12 beats by $0.01msn.com - November 13 at 7:14 PMDiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 13 at 7:14 PMEarnings Outlook For DiaMedica Therapeuticsbenzinga.com - November 10 at 1:49 PMDiaMedica Therapeutics to Attend the 14th Annual Craig-Hallum Alpha Select Conference November 16, 2023finance.yahoo.com - November 9 at 9:58 AMDiaMedica Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Business Update November 14, 2023finance.yahoo.com - November 6 at 8:33 AMDiaMedica Therapeutics Announces the Appointment of Ambarish Shah, Ph.D. as Chief Technology Officerfinance.yahoo.com - September 12 at 10:04 AMDiaMedica Therapeutics to Participate at Lake Street’s 7th Annual Best Ideas Growth Conferencefinance.yahoo.com - September 6 at 10:10 AMIs DiaMedica Therapeutics (DMAC) Stock Outpacing Its Medical Peers This Year?finance.yahoo.com - August 31 at 5:28 PMQ2 2023 DiaMedica Therapeutics Inc Earnings Callfinance.yahoo.com - August 15 at 10:12 PMDiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Resultsfinance.yahoo.com - August 14 at 6:00 PMDiaMedica Therapeutics to Report Second Quarter 2023 Financial Results and Provide a Business Update August 15, 2023finance.yahoo.com - August 8 at 10:46 AMDiaMedica Therapeutics to Attend the American Academy of Neurology Summer Conferencefinance.yahoo.com - July 18 at 12:59 PMDiaMedica Therapeutics Inc. (NASDAQ:DMAC) Sees Large Growth in Short Interestmarketbeat.com - July 14 at 3:24 PMDiaMedica Therapeutics (DMAC) Price Target Increased by 11.11% to 8.50msn.com - July 6 at 9:42 PMThree (3) Stocks Under $10 That Insiders Are Buyingmsn.com - July 5 at 12:08 PMThree (3) Stocks Under $10 That Insiders Are Buying insidertrades.com - July 5 at 10:35 AMDiaMedica Therapeutics raises $37.5 million for stroke and kidney treatmentbizjournals.com - June 26 at 6:23 PMDiaMedica Therapeutics Announces Closing of $37.5 Million Private Placementfinance.yahoo.com - June 26 at 9:50 AMOppenheimer Upgrades DiaMedica Therapeutics (DMAC)msn.com - June 22 at 3:15 PMOppenheimer Upgrades DiaMedica Therapeutics to Outperform, Announces $7 Price Targetbenzinga.com - June 22 at 12:47 PMBenzinga's Top Ratings Upgrades, Downgrades For June 22, 2023msn.com - June 22 at 12:47 PMDiaMedica Raises $37.5M Via Equity Offering, Aiding Development Activities For DM199msn.com - June 21 at 2:53 PMDiaMedica Therapeutics Says FDA Lifts Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Strokemarkets.businessinsider.com - June 21 at 9:52 AMDiaMedica Therapeutics Announces that the FDA Has Removed The Clinical Hold On DM199 Phase 2/3 Trial For Ischemic Strokefinance.yahoo.com - June 21 at 9:52 AMDiaMedica Therapeutics Announces $37.5 Million Private Placementfinance.yahoo.com - June 21 at 9:52 AM Get DiaMedica Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAC and its competitors with MarketBeat's FREE daily newsletter. Email Address AI finds its first serious application (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world. Click here to learn more about the booming eHealth industry DMAC Media Mentions By Week DMAC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DMAC News Sentiment▼0.910.41▲Average Medical News Sentiment DMAC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DMAC Articles This Week▼41▲DMAC Articles Average Week Get DiaMedica Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SELLAS Life Sciences Group News Allakos News PMV Pharmaceuticals News BioXcel Therapeutics News ProPhase Labs News Abeona Therapeutics News Milestone Pharmaceuticals News Genelux News BeyondSpring News Oramed Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DMAC) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
